ctDNA-based Minimal Residual Disease Detection for Resected Pancreatic Adenocarcinoma

Clinical trial NCT05479708 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05479708
Sponsor: BAIYONG SHEN
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

Pancreatic Cancer Resectable

Start date: 2023-08-09
Primary completion: 2028-01-01
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.